Pricing Log in Create free account
Saturday 17 October 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

104.88 0.20 +0.19%
Market cap
$181.1B
P/E
33.9×
Fwd P/E
22.9×
Dividend yield
2.40%
F-score
5/9
Altman Z
5.61
Beneish M
−2.50
Dividend safety
62/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Abbott Laboratories (ABT) EPS (diluted)

Alert me on EPS (diluted)

Abbott Laboratories's EPS (diluted) for fiscal 2025 was $3.72, down 51.3% from $7.64 in fiscal 2024. Over the twelve months to 30 June 2026 it was $3.09. Over the past ten years it has ranged from $0.27 (fiscal 2017) to $7.64 (fiscal 2024); the current reading is higher than 73% of that period. Abbott Laboratories ranks 20th of 147 Medical Devices companies by EPS (diluted).

EPS (diluted), annual

Embed this chart

Annual newest first

Period EPS (diluted) Change
FY2025 $3.72 (51.31%)
FY2024 $7.64 134.36%
FY2023 $3.26 (16.62%)
FY2022 $3.91 (0.76%)
FY2021 $3.94 57.60%
FY2020 $2.50 21.36%
FY2019 $2.06 54.89%
FY2018 $1.33 392.59%
FY2017 $0.27 (71.28%)
FY2016 $0.94 (67.81%)

Quarterly newest first

Period EPS (diluted) Change
Jun 2026 $0.53 (13.11%)
Mar 2026 $0.61 (39.60%)
Dec 2025 $1.01 7.45%
Sep 2025 $0.94 (6.93%)
42 more quarters

Against its own ten years

Low $0.27 High $7.64
Ten-year median $2.92
Current reading's percentile 73

EPS (diluted) against peers

Company EPS (diluted)
SYK Stryker Corporation compare $9.65
STE STERIS plc compare $8.18
GEHC GE HealthCare Technologies Inc. compare $4.36
MDT Medtronic PLC compare $4.06
ABT Abbott Laboratories $3.09
DXCM DexCom, Inc. compare $2.53
BSX Boston Scientific Corporation compare $2.47
EW Edwards Lifesciences Corporation compare $1.74
PHG Koninklijke Philips N.V. compare $1.36

What EPS (diluted) is

Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.

Reported line item

The full definition of EPS (diluted) →

More on ABT